Disney, DirecTV fail to reach distribution deal [Yahoo! Finance Canada]
Neurocrine Biosciences, Inc. (NBIX)
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
neurocrine.com/about-us/webcasts-presentations
Company Research
Source: Yahoo! Finance Canada
(Reporting by Dawn Chmielewski and Urvi Dugar in Bengaluru; Editing by Cynthia Osterman) Latest Stories Yahoo Sports Disney channels, including ESPN and ABC, went dark on DirecTV on Sunday night in a carriage dispute between the satellite TV provider and TV conglomerate. Reuters Azerbaijan's ruling party was set to retain its majority in Sunday's snap parliamentary election, election officials said, in the country's first vote since staging a lightning offensive a year ago to recapture the breakaway territory of Karabakh. President Ilham Aliyev's party was on course to win 67 out of 125 seats in the parliament, based on 91% of the vote count, Central Election Commission chief Mazahir Panakhov said at a media conference. Just over 2 million people in Azerbaijan, a country that's bounded by the Caspian Sea and Caucasus Mountains, voted, bringing the turnout at the time of the close of polling stations to 37.3%, Panakhov said. Reuters North Korean leader Kim Jong Un has ca
Show less
Read more
Impact Snapshot
Event Time:
NBIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBIX alerts
High impacting Neurocrine Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
NBIX
News
- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.MarketBeat
- Neurocrine's Phase II schizophrenia trial fails to meet primary endpoint [Yahoo! Finance]Yahoo! Finance
- Stocks making the biggest moves after hours: Adobe, RH, Oracle and more [CNBC]CNBC
- Neurocrine Biosciences Provides Update on ERUDITE™ Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with SchizophreniaPR Newswire
- Neurocrine Biosciences to Participate at the 2024 Cantor Global Healthcare ConferencePR Newswire
NBIX
Earnings
- 8/1/24 - Beat
NBIX
Sec Filings
- 9/13/24 - Form 144
- 8/28/24 - Form 8-K
- 8/16/24 - Form 4
- NBIX's page on the SEC website